4//SEC Filing
Stehman-Breen Catherine 4
Accession 0001209191-22-034499
CIK 0001818794other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:09 PM ET
Size
5.3 KB
Accession
0001209191-22-034499
Insider Transaction Report
Form 4
Stehman-Breen Catherine
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-03+19,596→ 19,596 totalExercise: $4.58Exp: 2032-06-02→ Common Stock (19,596 underlying)
Footnotes (1)
- [F1]This option was granted on June 3, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 3, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001702233
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:09 PM ET
- Size
- 5.3 KB